目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Technology
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global antibody drug conjugates market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global antibody drug conjugates market 2018 - 2022 ($ billion)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
4.3 Technnology Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Technnology Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Breast cancer - Market size and forecast 2023-2028
Exhibit 34: Chart on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
6.4 Blood cancer - Market size and forecast 2023-2028
Exhibit 38: Chart on Blood cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Blood cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Blood cancer - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Blood cancer - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Exhibit 42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Application
Exhibit 46: Market opportunity by Application ($ billion)
Exhibit 47: Data Table on Market opportunity by Application ($ billion)

7 Market Segmentation by Technology
7.1 Market segments
Exhibit 48: Chart on Technology - Market share 2023-2028 (%)
Exhibit 49: Data Table on Technology - Market share 2023-2028 (%)
7.2 Comparison by Technology
Exhibit 50: Chart on Comparison by Technology
Exhibit 51: Data Table on Comparison by Technology
7.3 Cleavable linker - Market size and forecast 2023-2028
Exhibit 52: Chart on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Cleavable linker - Year-over-year growth 2023-2028 (%)
7.4 Non-cleavable linker - Market size and forecast 2023-2028
Exhibit 56: Chart on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
7.5 Linkerless - Market size and forecast 2023-2028
Exhibit 60: Chart on Linkerless - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Linkerless - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Linkerless - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Linkerless - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Technology
Exhibit 64: Market opportunity by Technology ($ billion)
Exhibit 65: Data Table on Market opportunity by Technology ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2023-2028 (%)
Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ billion)
Exhibit 108: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 115: AbbVie Inc. - Overview
Exhibit 116: AbbVie Inc. - Product / Service
Exhibit 117: AbbVie Inc. - Key news
Exhibit 118: AbbVie Inc. - Key offerings
12.4 ADC Therapeutics SA
Exhibit 119: ADC Therapeutics SA - Overview
Exhibit 120: ADC Therapeutics SA - Product / Service
Exhibit 121: ADC Therapeutics SA - Key offerings
12.5 Astellas Pharma Inc.
Exhibit 122: Astellas Pharma Inc. - Overview
Exhibit 123: Astellas Pharma Inc. - Product / Service
Exhibit 124: Astellas Pharma Inc. - Key news
Exhibit 125: Astellas Pharma Inc. - Key offerings
12.6 AstraZeneca Plc
Exhibit 126: AstraZeneca Plc - Overview
Exhibit 127: AstraZeneca Plc - Product / Service
Exhibit 128: AstraZeneca Plc - Key news
Exhibit 129: AstraZeneca Plc - Key offerings
12.7 Daiichi Sankyo Co. Ltd.
Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
12.8 F. Hoffmann La Roche Ltd.
Exhibit 134: F. Hoffmann La Roche Ltd. - Overview
Exhibit 135: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 136: F. Hoffmann La Roche Ltd. - Key news
Exhibit 137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 138: F. Hoffmann La Roche Ltd. - Segment focus
12.9 Gilead Sciences Inc.
Exhibit 139: Gilead Sciences Inc. - Overview
Exhibit 140: Gilead Sciences Inc. - Product / Service
Exhibit 141: Gilead Sciences Inc. - Key news
Exhibit 142: Gilead Sciences Inc. - Key offerings
12.10 ImmunoGen Inc.
Exhibit 143: ImmunoGen Inc. - Overview
Exhibit 144: ImmunoGen Inc. - Product / Service
Exhibit 145: ImmunoGen Inc. - Key offerings
12.11 Merck KGaA
Exhibit 146: Merck KGaA - Overview
Exhibit 147: Merck KGaA - Business segments
Exhibit 148: Merck KGaA - Key news
Exhibit 149: Merck KGaA - Key offerings
Exhibit 150: Merck KGaA - Segment focus
12.12 Mersana Therapeutics Inc.
Exhibit 151: Mersana Therapeutics Inc. - Overview
Exhibit 152: Mersana Therapeutics Inc. - Product / Service
Exhibit 153: Mersana Therapeutics Inc. - Key offerings
12.13 Pfizer Inc.
Exhibit 154: Pfizer Inc. - Overview
Exhibit 155: Pfizer Inc. - Product / Service
Exhibit 156: Pfizer Inc. - Key news
Exhibit 157: Pfizer Inc. - Key offerings
12.14 Regeneron Pharmaceuticals Inc.
Exhibit 158: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 159: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 160: Regeneron Pharmaceuticals Inc. - Key offerings
12.15 Seagen Inc.
Exhibit 161: Seagen Inc. - Overview
Exhibit 162: Seagen Inc. - Key offerings
12.16 Syngene International Ltd.
Exhibit 163: Syngene International Ltd. - Overview
Exhibit 164: Syngene International Ltd. - Product / Service
Exhibit 165: Syngene International Ltd. - Key offerings
12.17 Takeda Pharmaceutical Co. Ltd.
Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 168: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 169: Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global antibody drug conjugates market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Technnology Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Breast cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Breast cancer - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Blood cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Blood cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Blood cancer - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Blood cancer - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Application ($ billion)
Exhibits47: Data Table on Market opportunity by Application ($ billion)
Exhibits48: Chart on Technology - Market share 2023-2028 (%)
Exhibits49: Data Table on Technology - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Technology
Exhibits51: Data Table on Comparison by Technology
Exhibits52: Chart on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Non-cleavable linker - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Non-cleavable linker - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Linkerless - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Linkerless - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Linkerless - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Linkerless - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Technology ($ billion)
Exhibits65: Data Table on Market opportunity by Technology ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share by geography 2023-2028 (%)
Exhibits68: Data Table on Market share by geography 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity by geography ($ billion)
Exhibits108: Data Tables on Market opportunity by geography ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: ADC Therapeutics SA - Overview
Exhibits120: ADC Therapeutics SA - Product / Service
Exhibits121: ADC Therapeutics SA - Key offerings
Exhibits122: Astellas Pharma Inc. - Overview
Exhibits123: Astellas Pharma Inc. - Product / Service
Exhibits124: Astellas Pharma Inc. - Key news
Exhibits125: Astellas Pharma Inc. - Key offerings
Exhibits126: AstraZeneca Plc - Overview
Exhibits127: AstraZeneca Plc - Product / Service
Exhibits128: AstraZeneca Plc - Key news
Exhibits129: AstraZeneca Plc - Key offerings
Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits134: F. Hoffmann La Roche Ltd. - Overview
Exhibits135: F. Hoffmann La Roche Ltd. - Business segments
Exhibits136: F. Hoffmann La Roche Ltd. - Key news
Exhibits137: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits138: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits139: Gilead Sciences Inc. - Overview
Exhibits140: Gilead Sciences Inc. - Product / Service
Exhibits141: Gilead Sciences Inc. - Key news
Exhibits142: Gilead Sciences Inc. - Key offerings
Exhibits143: ImmunoGen Inc. - Overview
Exhibits144: ImmunoGen Inc. - Product / Service
Exhibits145: ImmunoGen Inc. - Key offerings
Exhibits146: Merck KGaA - Overview
Exhibits147: Merck KGaA - Business segments
Exhibits148: Merck KGaA - Key news
Exhibits149: Merck KGaA - Key offerings
Exhibits150: Merck KGaA - Segment focus
Exhibits151: Mersana Therapeutics Inc. - Overview
Exhibits152: Mersana Therapeutics Inc. - Product / Service
Exhibits153: Mersana Therapeutics Inc. - Key offerings
Exhibits154: Pfizer Inc. - Overview
Exhibits155: Pfizer Inc. - Product / Service
Exhibits156: Pfizer Inc. - Key news
Exhibits157: Pfizer Inc. - Key offerings
Exhibits158: Regeneron Pharmaceuticals Inc. - Overview
Exhibits159: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits160: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits161: Seagen Inc. - Overview
Exhibits162: Seagen Inc. - Key offerings
Exhibits163: Syngene International Ltd. - Overview
Exhibits164: Syngene International Ltd. - Product / Service
Exhibits165: Syngene International Ltd. - Key offerings
Exhibits166: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits167: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits168: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits169: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits170: Inclusions checklist
Exhibits171: Exclusions checklist
Exhibits172: Currency conversion rates for US$
Exhibits173: Research methodology
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Information sources
Exhibits176: List of abbreviations